Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Lixia Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2304-7536; OpenAlex author ID A5100442914. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic Duct in Pre-Diagnostic CT Scans. Co-author DOI 10.3390/cancers17111886↗
  2. An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images. Co-author DOI 10.3389/fonc.2024.1378691↗
  3. Chemical Exchange Saturation Transfer for Pancreatic Ductal Adenocarcinoma Evaluation. Co-author DOI 10.1097/mpa.0000000000002059↗
  4. Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2022.1007134↗
  5. Risk prediction of pancreatic cancer using AI analysis of pancreatic subregions in computed tomography images. Co-author DOI 10.3389/fonc.2022.1007990↗
  6. Six-dimensional quantitative DCE MR Multitasking of the entire abdomen: Method and application to pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/mrm.28167↗
  7. Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells. First author PMID 27822410↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephen Jacob Pandol · 6 shared papers, 2020–2025 · strength 0.93
  2. Srinivas Gaddam · 6 shared papers, 2020–2025 · strength 0.93
  3. Debiao Li · 6 shared papers, 2020–2025 · strength 0.93
  4. Sehrish Javed · 3 shared papers, 2022–2025 · strength 0.56
  5. Touseef Ahmad Qureshi · 3 shared papers, 2022–2025 · strength 0.56
  6. Zhaoyang Fan · 3 shared papers, 2020–2022 · strength 0.37
  7. Simon K. Lo · 3 shared papers, 2020–2022 · strength 0.37
  8. Andrew Eugene Hendifar · 3 shared papers, 2020–2022 · strength 0.37
  9. Nan Wang · 3 shared papers, 2020–2022 · strength 0.37
  10. Anthony G Christodoulou · 3 shared papers, 2020–2022 · strength 0.37
  11. Christie Y. Jeon · 2 shared papers, 2022–2025 · strength 0.32
  12. Vahid Yaghmai · 1 shared paper, 2025 · strength 0.18
  13. Temel Tirkes · 1 shared paper, 2025 · strength 0.18
  14. Camila Lopes Vendrami · 1 shared paper, 2025 · strength 0.18
  15. James Leonard Buxbaum · 1 shared paper, 2025 · strength 0.18
  16. Frank H. Miller · 1 shared paper, 2025 · strength 0.18
  17. Wolfram Goessling · 1 shared paper, 2025 · strength 0.18
  18. Yasmin Genevieve Hernandez-Barco · 1 shared paper, 2025 · strength 0.18
  19. Wansu Chen · 1 shared paper, 2022 · strength 0.14
  20. Wensha Yang · 1 shared paper, 2020 · strength 0.10
  21. Richard Tuli · 1 shared paper, 2020 · strength 0.10
  22. Jingna Su · 1 shared paper, 2016 · strength 0.06
  23. Xuyuan Yin · 1 shared paper, 2016 · strength 0.06
  24. Xiuxia Zhou · 1 shared paper, 2016 · strength 0.06
  25. Zhiwei Peter Wang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.